A First Time in Human Study of GSK586529 in Healthy Volunteers

NCT00703547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG: GSK586529 capsules
DRUG: GSK586529 tablets
DRUG: Placebo

Sponsor

GlaxoSmithKline